Company: VEEV
Filing Date: 2025-05-05
Form Type: DEF 14A
Source: 0001140361-25-017353
Chunk: 67

Company: VEEVA SYSTEMS INC
Filing Date: 2025-05-05
Form: DEF 14A
Chunk 67
---
 our other NEOs from their respective equity grants–during the applicable fiscal year. Additionally, unlike full-value equity awards (such as restricted stock units), which are more common for executive officer grants at other public companies, Mr. Gassner will receive no financial benefit from the 2024 CEO Options unless our stock price is above the exercise price of $236.90 per share at the time of exercise. Description of Relationship Between Our Cumulative TSR and Our Peer Group Cumulative TSR The following chart compares the cumulative TSR on our common stock for the last five completed fiscal years to that of our peer group in the S&P 1500 Application Software Index over the same period. The chart assumes $100 was invested at the close of market on January 31, 2020 in our common stock and the S&P 1500 Application Software Index and assumes the reinvestment of any dividends. The stock price performance on the chart is not necessarily indicative of future stock price performance.

| Veeva Systems Inc. | 2025 Proxy Statement63 |

TABLE OF CONTENTS

Our Pay Equity Compensation Plan Information The following table provides information as of January 31, 2025 with respect to the shares of our common stock that may be issued under our existing equity compensation plans.

| Plan Category                                          |     |         Number of 
        Securities 
 to be Issued Upon 
       Exercise of 
       Outstanding 
    Options, RSUs, 
      Warrants and 
            Rights |     |  Weighted Average 
 Exercise Price of 
       Outstanding 
 Options, Warrants 
    and Rights (1) |     |           Number of 
          Securities 
           Remaining 
           Available 
 for Future Issuance 
        Under Equity 
        Compensation 
           Plans (2) |
| Equity compensation plans approved by shareholders     |     |        15,513,947 |     |           $177.65 |     |          52,180,933 |
| Equity compensation plans not approved by shareholders |     |                 — |     |                 — |     |                   — |
| Total                                                  |     |        15,513,947 |     |                   |     |          52,180,933 |

| (1) | The weighted average exercise price does not take into account outstanding RSUs. |

| (2) | Included in this amount are 4,897,856 shares available for future issuance under the 2013 Employee Stock Purchase Plan (“ESPP”). |

| (3) | On the first business day